CHROMOCELL THERAPEUTICS CORPORATION

Highlights Chromocell Therapeutics Corporation

Equities

CHRO

US1711261057

Market Closed - Nyse Other stock markets 01:40:00 15/06/2024 am IST			5-day change	1st Jan Change
1.3 ^USD	-3.70%		-8.45%	0.00%

15/05	Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
16/04	Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05	CI
Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	17/04	CI
Chromocell Therapeutics Corporation Announces Formal Launch of Eye Pain Treatment Program	21/03	CI
Chromocell Therapeutics Corporation has completed an IPO in the amount of $6.6 million.	15/02	CI
Chromocell Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	17/01	CI
Chromocell Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	02/23/02	CI
Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	30/23/30	CI
Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	02/23/02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
CHRO Stock
News Chromocell Therapeutics Corporation
Highlights

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer